Kardigan Files for IPO to Fund Cardiovascular Disease Treatment
Kardigan Inc. filed for a US initial public offering that will help fund three late-stage drugs that target the root cause of cardiovascular diseases.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.